Picard Medical, Inc.(PMI)Stock Analysis

AI stock analysis and institutional research for Picard Medical, Inc. (PMI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PMI at 30.6/100 on a 32-signal composite quality model, placing it at rank #2,481 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Picard Medical, Inc. reports quarterly revenue of $3.0M, net income of $-5.7M, free cash flow of $-1.4M. Top institutional holders of PMI by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, AQR CAPITAL MANAGEMENT, JANE STREET GROUP, based on the most recent SEC filings. PMI trades on the NYSE exchange and files with the SEC under CIK 2030617. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PMI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Picard Medical, Inc. directly from SEC EDGAR. Picard Medical, Inc.'s 13F Pro composite quality score has ranged between 31 and 33 since 2026, currently 30.6 — a stable long-term trajectory across 9 quarterly and live scoring snapshots.